Medicare Enrolled

Dr. Jignesh Shah, MD

Internal Medicine · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
444 FM 1959 RD, Houston, TX 77034
2814819400
In practice since 2007 (19 years)
NPI: 1063550291 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shah

Dr. Jignesh Shah is an internal medicine in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Shah performed 1,355 Medicare services across 805 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shah received a total of $84,330 from 40 pharmaceutical and/or device companies across 562 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 27% volume in TX$ $84,330 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,355
Medicare services
Top 27% in TX for internal medicine
805
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Chronic care management, additional 20 min/month349$39$152
Chronic care management, first 20 min/month196$51$100
Office visit, established patient (30-39 min)178$95$218
Office visit, established patient (20-29 min)108$61$148
Upper GI endoscopy with biopsy101$86$680
Hospital follow-up visit, moderate complexity86$60$146
Removal of polyps or growths of large bowel using an endoscope with mechanical snare66$209$1,067
Initial hospital admission, moderate complexity56$103$278
New patient office visit (45-59 min)49$119$333
New patient office visit (30-44 min)45$52$219
Hospital follow-up visit, low complexity27$41$80
Colonoscopy with biopsy26$90$847
Hospital follow-up visit, high complexity24$97$212
Initial hospital admission, high complexity19$141$411
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment13$16$75
Colorectal cancer screening; colonoscopy on individual at high risk12$182$778
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$84,330
Total received (2018-2024)
Avg $12,047/year across 7 years
Top 2% in TX for internal medicine
40
Companies
562
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$71,276 (84.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,012 (8.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,990 (5.9%)
Scientific / Research
Research funding and grants
$1,051 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$33,490
2023
$10,333
2022
$2,680
2021
$4,722
2020
$1,103
2019
$7,959
2018
$24,043

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EVOKE PHARMA, INC.
$31,000
Synergy Pharmaceuticals Inc
$22,689
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19,229
RedHill Biopharma Inc.
$2,059
Ardelyx, Inc.
$1,911
Takeda Pharmaceuticals U.S.A., Inc.
$1,327
Braintree Laboratories, Inc.
$1,132
Medtronic USA, Inc.
$941
AbbVie Inc.
$794
QOL Medical, LLC
$413
Celgene Corporation
$332
Ironwood Pharmaceuticals, Inc
$287
ABBVIE INC.
$274
Allergan Inc.
$224
Merck Sharp & Dohme LLC
$197
Janssen Biotech, Inc.
$192
Gilead Sciences, Inc.
$147
Inari Medical, Inc.
$140
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$119
AbbVie, Inc.
$108
Silk Road Medical, Inc.
$97
Pulmonx Corporation
$92
IRONWOOD PHARMACEUTICALS, INC
$91
PFIZER INC.
$86
Abbott Laboratories
$57
Romark Laboratories, LC
$51
Shionogi Inc
$33
Merck Sharp & Dohme Corporation
$32
Lilly USA, LLC
$31
CONMED Corporation
$29
Madrigal Pharmaceuticals
$28
FUJIFILM Healthcare Americas Corporation
$27
Boston Scientific Corporation
$26
Janssen Pharmaceuticals, Inc
$25
Ambu Inc.
$25
Axonics, Inc.
$23
Intercept Pharmaceuticals, Inc.
$19
Medtronic Vascular, Inc.
$17
Evoke Pharma, Inc.
$13
Cook Medical LLC
$12
Top 3 companies account for 86.5% of total payments
Associated products mentioned in payments ›
APRISO · Alinia · Alinia Tablets 500mg 30 count bottle · Axonics r-SNM System · CHARTIS CATHETER · CONMED GENERATORS · CREON · CardioMEMS HF System · CareLink · Cook Medical Hemospray · DIFICID · ENROUTE Transcarotid Neuroprotection System · ENTYVIO · EOHILIA · Entyvio · FLOWTRIEVER CATHETER · FUJIFILM · GATTEX · GIMOTI · General - Therapies · HUMIRA · Humira · IBSRELA · INTERSTIM · LINZESS · LifeVest · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Mavyret · Motegrity · Mulpleta · OCALIVA · OMVOH · REMICADE · RESMETIROM · S · SKYRIZI · STELARA · SUTAB · Sucraid · TALICIA · TREMFYA · TRULANCE · Talicia · Trulance · VIBERZI · XARELTO · XELJANZ · XIFAXAN · ZEPOSIA · movantik · talicia
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for internal medicine in TX.

Equivalent to $6,224 per 100 Medicare services performed
Looking for a internal medicine in Houston?
Compare internal medicines in the Houston area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
2,211
Per 100K population
46.5
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE SOUTHEAST
2.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 27% in TX), and high industry engagement (speaking/promotional, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Shah experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Shah performed 349 chronic care management, additional 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $84,330 from 40 companies across 562 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other internal medicines in Houston?
Dr. Shah's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →